Scholars Central

EditorialPublished 30 Oct 2024

Emerging Biopharmaceuticals: Innovations in Drug Development and Therapeutic Applications

Authors: Habib Lance David

Department of Biochemistry, University of KwaZulu-Natal, South Africa

Clinical Pharmacology & Biopharmaceutics

Volume 13 · Issue 10 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The biopharmaceutical industry has witnessed significant advancements in drug development and therapeutic applications, driven by innovations in biotechnology and genomics. This review explores the emergence of biopharmaceuticals, focusing on novel therapeutic modalities, such as monoclonal antibodies, gene therapies, and personalized medicine. These innovations have revolutionized the treatment of various diseases, including cancer, autoimmune disorders, and genetic conditions, by enabling targeted therapies that enhance efficacy and minimize side effects. Additionally, the integration of artificial intelligence and machine learning in drug discovery is accelerating the identification of potential candidates and optimizing clinical trial designs. This article highlights key innovations, challenges in regulatory frameworks, and the future landscape of biopharmaceuticals, underscoring their potential to transform healthcare and improve patient outcomes

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Habib Lance David”